No Data
No Data
No Data
No Data
No Data
Microbot Medical Outlines Regulatory Goals and Investor Cautions
TipRanksApr 24 17:23 ET
Express News | Microbot Medical Anticipates Receiving 510(K) Clearance From FDA In H1 2025, And CE MARK Approval In H2 2025
Moomoo 24/7Apr 24 17:00 ET
Express News | Microbot Medical - Sees Receiving 510(K) Clearance From US Food & Drug Administration in the First Half of 2025, and Ce Mark Approval in H2 of 2025
Moomoo 24/7Apr 24 16:56 ET
Express News | HC Wainwright & Co. Maintains Buy on Microbot Medical, Lowers Price Target to $7
Moomoo 24/7Apr 17 05:52 ET
Microbot Medical Is Maintained at Buy by HC Wainwright & Co.
Microbot Medical Is Maintained at Buy by HC Wainwright & Co.
Dow JonesApr 16 07:35 ET
Microbot Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/16/2024 586.27% HC Wainwright & Co. $8 → $7 Maintains Buy 10/18/2023 684.31% HC Wainwright & Co. → $8 R
BenzingaApr 16 07:22 ET
No Data
No Data